Review article
Amiodarone-Induced Thyroid Dysfunction
Dtsch Arztebl 2007; 104(51-52): A-3550
; ; ; ;
For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.
| 1. | Amiodarone Trials Meta-Analysis Investigators: Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6 500 patients in randomized trials. Lancet 1997; 350: 1417–24. MEDLINE |
| 2. | Trip MD, Wiersinga WM, Plomp TA: Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991; 91: 507–11. MEDLINE |
| 3. | Martino E, Bartalena L, Bogazzi F, Braverman LE: The effect of amiodarone on the thyroid. Endocrine Rev 2001; 22: 240–54. MEDLINE |
| 4. | Basaria S, Cooper DS: Amiodarone and the thyroid. Am J Med 2005; 118: 706–14. MEDLINE |
| 5. | Harjai KJ, Licata AA: Effects of amiodarone on thyroid function. Ann Intern Med 1997; 126: 63–73. MEDLINE |
| 6. | Kahaly GJ, Dillmann WH: Thyroid hormone action in the heart. Endocrine Reviews 2005; 26: 704–28. MEDLINE |
| 7. | Brabant G, Kahaly GJ, Schicha H, Reiners C: Milde Formen der Schilddrüsenfehlfunktion. Dtsch Arztebl 2006; 103(31–32): A 2110–5. VOLLTEXT |
| 8. | Dietlein M, Schicha H: Amiodarone-induced thyrotoxicosis due to destructive thyroiditis. Therapeutic recommendations. Exp Clin Endocrinol Diab 2005; 113: 145–51. MEDLINE |
| 9. | Hermida JS, Jarry G, Tcheng E et al.: Radioiodine ablation of the thyroid to allow the reintroduction of amiodarone treatment in patients with a prior history of amiodarone-induced thyrotoxicosis. Am J Med 2004; 116: 345–8. MEDLINE |
| 10. | Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B: Practical guidelines for clinicians who treat patients with amiodarone. Arch Intern Med 2000; 160: 1741–8. MEDLINE |
| 11. | Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A, Martino E: Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin Endocrinol 2004; 61: 494–502. MEDLINE |
| 12. | Brennan MD, Erickson DZ, Carney JA: Nongoitrous (type I) amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo. Thyroid 1995; 5: 177–83. MEDLINE |
| 13. | Bogazzi F, Bartalena L, Brogioni S et al.: Color flow doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 1997; 7: 541–5. MEDLINE |
| 14. | Eaton SEM, Euinton HA, Newman CM, Weetman AP, Bennet WM: Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol 2002; 56: 33–8. MEDLINE |
| 15. | Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E: Serum Interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994; 78: 423–7. MEDLINE |
| 16. | O'Sullivan AJ, Lewis M, Diamond T: Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. Eur J Endocrinol 2006; 154: 533–6. MEDLINE |
| 17. | Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E: Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 1996; 81: 2930–3. MEDLINE |
| 18. | Woolf SH, Sox HC: The expert panel on preventive services: continuing the work of the USPSTF. Am J Prev Med 1991; 7: 326–30. MEDLINE |
| 19. | Wolff J: Perchlorate and the thyroid gland. Pharmacol Rev 1998; 50: 33–8. MEDLINE |
| 20. | Dickstein G, Shechner C, Adawi F, Kaplan J, Baron E, Ish-Shalom S: Lithium treatment in amiodarone-induced thyrotoxicosis. Am J Med 1997; 102: 454–8. MEDLINE |
| 21. | Hamoir E, Meurisse M, Defechereux T, Joris J, Vivario J, Hennen G: Surgical management of amiodarone-associated thyrotoxicosis: too risky or too effective? World J Surg 1998; 22: 537–42. MEDLINE |
| 22. | Bogazzi F, Bartalena L, Cosci C et al.: Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab 2003; 88: 1999–2002. MEDLINE |
| 23. | Ryan LE, Braverman LE, Cooper DS, Ladenson PW, Kloos RT: Can amiodarone be restarted after amiodarone-induced thyrotoxicosis? Thyroid 2004; 14: 149–53. MEDLINE |
| 24. | Bartalena L, Bogazzi F, Braverman LE, Martino E: Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest 2001; 24: 116–30. MEDLINE |
| 25. | Kathofer S, Thomas D, Karle CA: The novel antiarrhythmic drug dronedarone: comparison with amiodarone. Cardiovasc Drugs Rev 2005; 217–30. MEDLINE |
